Skip Navigation

An Open-Label Dose Escalation Multi-Center Phase I/II Clinical Trial of ECT204 T-Cell Therapy in Adults with Advanced Hepatocellular Carcinoma HCC.

Brief Summary

Type:
Liver

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04864054

Study #:
STUDY00149300

Start Date:
Dec 04, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04864054

View Complete Trial Details & Eligibility at ClinicalTrials.gov